Danimer Scientific — Q2 2021 Earnings Presentation
17 slides from Danimer Scientific's earnings presentation, Aug 16, 2021
Slide 1: Second Quarter 2021 Earnings Presentation
Second Quarter 2021 Earnings Presentation August 16, 2021
Slide 2: Disclaimer
Disclaimer This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitatio
Slide 3: Business Highlights
Business Highlights Business Highlights Closed acquisition of Novomer, a bioplastics innovator Acquisition advances our mission of reducing plastic waste Improves cost structure Increases production capacity Allows for quicker penetration of addressable market Helped launch the U.S. Plastics Pact’s
Slide 4: Blue Chip Customers Select Danimer to Help Fulfill their ESG Commitments
Blue Chip Customers Select Danimer to Help Fulfill their ESG Commitments 4
Slide 5: Novomer Acquisition Highly Aligned With Long-Term Growth Strategy
Novomer Acquisition Highly Aligned With Long-Term Growth Strategy Transaction Overview Strategic Rationale & Expected Benefits Improves Cost Structure: Substantially reduces CapEx / Ib and production costs. Novomer’s thermocatalytic conversion process is 10x faster than fermentation, offers producti
Slide 6: Nodax & Rinnovo Characteristics and Application Examples
Nodax® RinnovoTM Key Operating Parameters & Characteristics Bio-based Fermentation production Broad range of properties Good barrier properties Good heat resistance Biodegradability Application Examples Films Fibers Thermoformed sheet Injection molding Paper coatings Key Operating Parameters & Chara
Slide 7: Kentucky Extrusion Expansion Plan Comparison
Standalone Sales Kentucky Extrusion Expansion Plan Comparison 1 Old Plan: Module 1 estimated completion in 2023; module II estimated completion in 2024. 2 New Plan: Greenfield estimated to come online in mid-2023; Initial RinnovoTM plant estimated completion by early 2024. 3 New engineering estimate
Slide 8: Novomer Deal Dynamics to Accelerate Production and Reduce Costs
Novomer Deal Dynamics to Accelerate Production and Reduce Costs Return Metric Danimer Standalone Greenfield Danimer / Novomer Facility Network Finished Product Capacity (Ibs) 315mm ~390mm(1) Growth Capex $826mm +/- 25% $600mm – $700mm(2) ROIC ~25%(3) >35% Attractive Deal Dynamics (2025E) 1 Based on
Slide 9: Kentucky Phase II Expansion: Fermentation Chiller Building Update
Kentucky Phase II Expansion: Fermentation Chiller Building Update Greenfield Part 2 Nameplate capacity 125MM lbs.(1) 5 6 7 8 9 10 Kentucky Phase II Fermentation Chiller Building Kentucky Phase II Fermentation Chiller Building Pre Construction (December 2020) Construction Progress (August 2021) Kentu
Slide 10: Kentucky Phase II Expansion: Downstream Processing Facility Update
Kentucky Phase II Expansion: Downstream Processing Facility Update 9 10 Kentucky Phase II Downstream Processing Kentucky Phase II: Nameplate capacity of 45MM lbs of finished product expected to be completed in Q2 2022 Pre Construction (December 2020) Construction Progress (August 2021) Kentucky Phas
Slide 11: Kentucky Phase II Expansion: Extrusion Facility Update
Kentucky Phase II Expansion: Extrusion Facility Update 5 6 7 8 9 10 Kentucky Phase II Extrusion Facility Pre Construction (December 2020) Construction Progress (August 2021) Kentucky Phase II Extrusion Facility Kentucky Phase II: Nameplate capacity of 45MM lbs of finished product expected to be comp
Slide 12: Q2 2021 Financial Summary
Q2 2021 Financial Summary PHA increased to 29% of revenue vs 7% in Q2 2020 Completed warrant redemption in June, simplifying capital structure Costs influenced by: Elevated fixed-cost absorption at our Kentucky Facility as we scale up production Investments in headcount and salaries to support futur
Slide 13: Modeling Assumptions for 2021
Modeling Assumptions for 2021 Volumes: Phase I production at ~50% of nameplate capacity at the beginning of the year, expected to scale to 100% by year end Phase I turnaround completed in 2Q’21 to debottleneck and accelerate scale-up Phase II production expected to commence in 2Q’22 Operating Costs:
Slide 14: Danimer is a Next Generation Bioplastics Company
Danimer is a Next Generation Bioplastics Company ` Experienced Leadership Team and Board of Directors with Proven Track Record 6 Significant Tailwinds From Increased Corporate and Legislative Initiatives on Environmental Impact of Global Pollution Crisis 2 Highly Attractive PHA Technology Serves as
Slide 15: Danimer Scientific
4 danimer ~ scientific
Slide 16: EBITDA and EBITDAR Reconciliation
EBITDA and EBITDAR Reconciliation Note: 1 - Totals may not foot due to rounding.
Slide 17: Adjusted Gross Profit Reconciliation
Adjusted Gross Profit Reconciliation Note: 1 - Totals may not foot due to rounding.